Request Deal Involvement
Scilex-backed Semnur Pharmaceuticals to go public via a SPAC merger with Denali Capital Acquisition in a $2.5bn deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Paul Hastings
legal advisors
Winston & Strawn
or
Principals
target
SEMNUR PHARMACEUTICALS
bidder
DENALI CAPITAL ACQUISITION CORP
vendor
SCILEX HOLDING COMPANY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite